3 reasons you should bypass Commonwealth Bank of Australia shares

There's no denying the dominance of the bank, but its share mightn't prove so strong…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For a long time, Commonwealth Bank of Australia (ASX: CBA) shares have been one of the most reliable investments to count on.

While they have always offered safety and security as well as extremely generous dividends, they have also climbed in value at an incredible rate. In fact, they have risen more than 90% since mid-September 2011, far outpacing the likes of the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO), and an even more astonishing 149% over a 10-year period despite the heavy falls endured during the GFC. If you were to include all dividends paid, those numbers would be much higher…

However, it seems that the time may now have come where investors should stop relying on the stock, at least for the time being. Here are three reasons why the bank may not be such a great investment today.

  1. Like Westpac Banking Corp (ASX: WBC) and Australia and New Zealand Banking Group (ASX: ANZ), Commonwealth Bank's shares are flirting with their all-time highs. While that's great for current shareholders, there appears to be very limited upside potential for prospective investors with the stock already trading on a projected P/E ratio of 15.3 and a Price-Book ratio of 2.9.
  2. Those valuations suggest that investors expect the bank's earnings to continue growing strongly over the medium-to-long terms. Although the bank is recognising record-profits currently, its earnings could actually come under significant pressure in the future when interest rates and bad debt charges inevitably rise.
  3. One of the primary reasons behind the bank's rapid rise in recent years can be attributed to its juicy fully franked dividend yield, which has attracted investors in light of the low interest rate environment. However, the stock now yields just 4.6%. Although that is still a decent return, it could well be offset should the stock fall in value in the near-term.

Like many other Aussie blue-chip stocks, Commonwealth Bank just doesn't boast the same appeal anymore and shouldn't be purchased today. The good news is, there are still plenty of appealing buying opportunities to take advantage of, even with the S&P/ASX 200 sitting over 5,400 points…

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »